logo
  Join        Login             Stock Quote

Elsevier Announces the Launch of a Japanese User Interface to Scopus

Wednesday, April 17, 2013 4:58 AM


AMSTERDAM, April 17, 2013 /PRNewswire/ --

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of a Japanese user interface to Scopus. The interface provides Japanese users with the ability to find their way through the product in their local language.

Japanese users are now able to find the research information they are looking for more efficiently - expanding beyond Scopus' basic search functionalities to utilizing more advanced features such as personalization and alerts. As additional support all in-product help files have been translated into Japanese to further increase product understanding, helping Japanese librarians in their teaching and usage of Scopus.

"With a wide range of global content coverage and functionality, Scopus has become one of the most popular abstract and citation databases amongst researchers," said Cameron Ross, Head of Product Management, Scopus & Engineering Village at Elsevier. "We are delighted to be able to offer the Japanese user interface to further meet the needs of our Japanese customers and users."

"This local-language interface will help Japanese users accelerate the speed of their research, conduct analyses, determine their research strategy, provide trainings in a more efficient and effective way and gain information critical to develop their academic career," said Tetsu Ikeda, Director, Science & Technology, Elsevier Japan. "We are excited to hear the interest and positive feedback already coming from our customers."

To view the interface, go to http://www.scopus.com and click on "Japanese" in the footer or set your browser to Japanese.

About Scopus

Covering the world's research literature, Scopus is the largest abstract and citation database of peer-reviewed literature. Featuring smart tools to track, analyze and visualize research, Scopus was designed and developed with input from over 500 users and librarians internationally. Its unique database contains abstracts and references from nearly 20,500 peer-reviewed journals from more than 5,000 publishers worldwide, ensuring broad interdisciplinary coverage. In addition, Scopus not only offers users citation information about the articles covered, but also directly integrates Web and patent searches. Direct links to subscribed full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Harald Boersma
Director, Corporate Relations
Elsevier
+31-20-485-2736
h.boersma@elsevier.com

(Source: PR Newswire )
(Source: Quotemedia)

Advertisement
Advertisement



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.